Subbarao Myla, M.D., F.A.C.C., is the Medical Director, Cardiac and Endovascular Labs and Cardiovascular Research at Hoag Heart and Vascular Institute at Hoag Hospital Newport Beach. Dr. Myla leads the clinical direction of endovascular therapy and cardiovascular research at Hoag Heart and Vascular Institute. Under his leadership, Hoag has initiated more than 25 FDA-regulated clinical trials investigating a variety of innovative medical devices and procedures, all of which focus on stroke prevention. Hoag is one of only a handful of medical facilities in the western United States to participate in these studies. Dr. Myla also showcases leading-edge techniques to the medical and scientific community through workshops, live demonstration courses and preceptorships. One of the most extensive projects to-date involves computer-generated simulation as an instructional tool for physicians. The endeavor is aimed at accelerating the educational process in endovascular therapy.
Dr. Myla received his medical degree from Guntur Medical College at Nagarjuna University in India and went on to do his residency training at the University of British Columbia in Vancouver, Canada followed by residency training at several renowned New York hospitals. Dr. Myla then completed a cardiology and interventional cardiology fellowship at the State University of New York, Down State Coney Island Hospital, and Maimonides Medical Center in Brooklyn. He is certified by the American Board of Internal Medicine in interventional cardiology, critical care medicine, cardiology and internal medicine. Throughout his career, he has been named a fellow of the American College of Cardiology (FACC), a fellow of the Society of Cardiovascular Angiography & Intervention (FSCAI), a member of the International Society of Endovascular Specialists (ISES) and president of the non-profit Foundation for Endovascular Education and Research (FEVER). He is the Program Director of the Hoag Endovascular Summit. Dr. Myla is widely published in professional and peer-reviewed journals and has authored a number of textbook chapters. He has extensive experience in clinical trials and carotid interventional trials in the groundbreaking field of cardiology. Dr. Myla also directs catheterization and endovascular educational conferences.